Contact
searchSearch
HMP Global
Login

Targeted Therapies for Relapsing/Remitting Pediatric Low-Grade Glioma (R/R pLGG)

Podcasts
Podcast: Targeted Therapies for Relapsing/Remitting Pediatric Low-Grade Glioma (R/R pLGG)
05/13/2025
Dr Eugene Hwang delves into the evolving landscape of MEK and BRAF inhibitors for pediatric low-grade glioma (pLGG), comparing efficacy, side effects, and next-gen strategies shaping frontline and salvage care.
Dr Eugene Hwang delves into the evolving landscape of MEK and BRAF inhibitors for pediatric low-grade glioma (pLGG), comparing efficacy, side effects, and next-gen strategies shaping frontline and salvage care.
Dr Eugene Hwang delves into the...
05/13/2025
Oncology
Day One Article 2
Blog
Article: Targeted Therapies for Relapsing/Remitting Pediatric Low-Grade Glioma (R/R pLGG)
05/13/2025
With FDA-approved BRAF, MEK, and pan-RAF inhibitors transforming pediatric low-grade glioma (pLGG) care, learn how molecular targeting of MAPK pathway alterations is redefining frontline treatment strategies and outcomes.
With FDA-approved BRAF, MEK, and pan-RAF inhibitors transforming pediatric low-grade glioma (pLGG) care, learn how molecular targeting of MAPK pathway alterations is redefining frontline treatment strategies and outcomes.
With FDA-approved BRAF, MEK, and...
05/13/2025
Oncology
Day One Video Preview
Videos
Video: Targeted Therapies for Relapsing/Remitting Pediatric Low-Grade Glioma (R/R pLGG)
05/13/2025
Dr Eugene Hwang explores the expanding role of MEK and BRAF inhibitors in treating recurrent pediatric low-grade glioma (pLGG), offering insights into efficacy, toxicity, dosing strategies, and emerging immunotherapy potential.
Dr Eugene Hwang explores the expanding role of MEK and BRAF inhibitors in treating recurrent pediatric low-grade glioma (pLGG), offering insights into efficacy, toxicity, dosing strategies, and emerging immunotherapy potential.
Dr Eugene Hwang explores the...
05/13/2025
Oncology
Day One Info 2
Infographic
Infographic: Targeted Therapies for Relapsing/Remitting Pediatric Low-Grade Glioma (R/R pLGG)
04/01/2025
Any views and opinions expressed are those of the author/presenter, and do not necessarily reflect the views, policy, or position of the Oncology Learning Network, HMP Global, and its employees and affiliates.
Any views and opinions expressed are those of the author/presenter, and do not necessarily reflect the views, policy, or position of the Oncology Learning Network, HMP Global, and its employees and affiliates.
Any views and opinions expressed...
04/01/2025
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use